ATE412750T1 - Antigen aus streptococcus pyogenes - Google Patents
Antigen aus streptococcus pyogenesInfo
- Publication number
- ATE412750T1 ATE412750T1 AT01951286T AT01951286T ATE412750T1 AT E412750 T1 ATE412750 T1 AT E412750T1 AT 01951286 T AT01951286 T AT 01951286T AT 01951286 T AT01951286 T AT 01951286T AT E412750 T1 ATE412750 T1 AT E412750T1
- Authority
- AT
- Austria
- Prior art keywords
- antigen
- streptococcus pyogenes
- streptococcus
- prophylaxis
- antigens
- Prior art date
Links
- 239000000427 antigen Substances 0.000 title abstract 3
- 102000036639 antigens Human genes 0.000 title abstract 3
- 108091007433 antigens Proteins 0.000 title abstract 3
- 241000193996 Streptococcus pyogenes Species 0.000 title abstract 2
- 241001505901 Streptococcus sp. 'group A' Species 0.000 abstract 2
- 244000052616 bacterial pathogen Species 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
- 229940124856 vaccine component Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US21646500P | 2000-07-06 | 2000-07-06 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE412750T1 true ATE412750T1 (de) | 2008-11-15 |
Family
ID=22807177
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT01951286T ATE412750T1 (de) | 2000-07-06 | 2001-07-06 | Antigen aus streptococcus pyogenes |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US7247308B2 (enExample) |
| EP (1) | EP1297145B1 (enExample) |
| JP (1) | JP4718099B2 (enExample) |
| AT (1) | ATE412750T1 (enExample) |
| AU (1) | AU7227001A (enExample) |
| BR (1) | BR0112497A (enExample) |
| CA (1) | CA2413576C (enExample) |
| DE (1) | DE60136360D1 (enExample) |
| ES (1) | ES2316458T3 (enExample) |
| WO (1) | WO2002004495A2 (enExample) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU7227001A (en) * | 2000-07-06 | 2002-01-21 | Shire Biochem Inc | Streptococcus pyogenes antigens |
| US7939087B2 (en) | 2000-10-27 | 2011-05-10 | Novartis Vaccines And Diagnostics, Inc. | Nucleic acids and proteins from Streptococcus groups A & B |
| DE60134494D1 (de) * | 2000-12-21 | 2008-07-31 | Id Biomedical Corp | Antigene aus streptococcus pyogenes und zugehörige dna-fragmente |
| WO2004018646A2 (en) * | 2002-08-26 | 2004-03-04 | Chiron Corporation | Conserved and specific streptococcal genomes |
| PT1648500E (pt) | 2003-07-31 | 2014-10-10 | Novartis Vaccines & Diagnostic | Composições imunogénicas para estreptococos piogenes |
| WO2005017093A2 (en) * | 2003-08-15 | 2005-02-24 | Id Biomedical Corporation | Polypeptides of streptococcus pyogenes |
| US8945589B2 (en) * | 2003-09-15 | 2015-02-03 | Novartis Vaccines And Diagnostics, Srl | Immunogenic compositions for Streptococcus agalactiae |
| US20090317420A1 (en) * | 2004-07-29 | 2009-12-24 | Chiron Corporation | Immunogenic compositions for gram positive bacteria such as streptococcus agalactiae |
| US7838010B2 (en) * | 2004-10-08 | 2010-11-23 | Novartis Vaccines And Diagnostics S.R.L. | Immunogenic and therapeutic compositions for Streptococcus pyogenes |
| GB2428006A (en) * | 2005-07-07 | 2007-01-17 | Jevgenis Morov | AMI-3 vaccine comprising group A Streptococcus pyogenes bacteria |
| DK2054431T3 (da) * | 2006-06-09 | 2012-01-02 | Novartis Ag | Konformere af bakterielle adhæsiner |
| CA2668018A1 (en) * | 2006-10-30 | 2008-09-12 | Novartis Ag | Immunogenic and therapeutic compositions for streptococcus pyogenes |
| US8287885B2 (en) | 2007-09-12 | 2012-10-16 | Novartis Ag | GAS57 mutant antigens and GAS57 antibodies |
| AU2008339551B2 (en) | 2007-12-21 | 2013-10-24 | Glaxosmithkline Biologicals S.A. | Mutant forms of streptolysin O |
| AU2012271336B2 (en) | 2011-06-17 | 2017-03-02 | University Of Tennessee Research Foundation | Group A streptococcus multivalent vaccine |
| AU2014214613A1 (en) | 2013-02-11 | 2015-08-13 | University Of Tennessee Research Foundation | Group A streptococcal M-related proteins and methods of use |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0916726A1 (en) * | 1997-11-13 | 1999-05-19 | Rijksuniversiteit te Groningen | Attaching substances to micro-organisms |
| AU7227001A (en) | 2000-07-06 | 2002-01-21 | Shire Biochem Inc | Streptococcus pyogenes antigens |
-
2001
- 2001-07-06 AU AU7227001A patent/AU7227001A/xx active Pending
- 2001-07-06 WO PCT/CA2001/001001 patent/WO2002004495A2/en not_active Ceased
- 2001-07-06 EP EP01951286A patent/EP1297145B1/en not_active Expired - Lifetime
- 2001-07-06 ES ES01951286T patent/ES2316458T3/es not_active Expired - Lifetime
- 2001-07-06 BR BR0112497-8A patent/BR0112497A/pt not_active IP Right Cessation
- 2001-07-06 CA CA2413576A patent/CA2413576C/en not_active Expired - Fee Related
- 2001-07-06 AT AT01951286T patent/ATE412750T1/de not_active IP Right Cessation
- 2001-07-06 DE DE60136360T patent/DE60136360D1/de not_active Expired - Lifetime
- 2001-07-06 US US10/332,231 patent/US7247308B2/en not_active Expired - Lifetime
- 2001-07-06 JP JP2002509358A patent/JP4718099B2/ja not_active Expired - Fee Related
-
2007
- 2007-07-09 US US11/775,131 patent/US7811585B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| DE60136360D1 (de) | 2008-12-11 |
| JP4718099B2 (ja) | 2011-07-06 |
| US7247308B2 (en) | 2007-07-24 |
| JP2004502446A (ja) | 2004-01-29 |
| EP1297145B1 (en) | 2008-10-29 |
| EP1297145A2 (en) | 2003-04-02 |
| WO2002004495A3 (en) | 2002-06-13 |
| CA2413576A1 (en) | 2002-01-17 |
| WO2002004495A2 (en) | 2002-01-17 |
| AU7227001A (en) | 2002-01-21 |
| US20030165528A1 (en) | 2003-09-04 |
| US20080038268A1 (en) | 2008-02-14 |
| ES2316458T3 (es) | 2009-04-16 |
| CA2413576C (en) | 2012-11-13 |
| US7811585B2 (en) | 2010-10-12 |
| BR0112497A (pt) | 2003-11-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BE2021C506I2 (enExample) | ||
| ATE412750T1 (de) | Antigen aus streptococcus pyogenes | |
| ATE542829T1 (de) | Impfstoff | |
| ATE426412T1 (de) | Adjuvante influenza-vakzine | |
| WO2004030608A3 (en) | Nanoemulsion vaccines | |
| AU2001278003A1 (en) | Bacteriophage having multiple host range | |
| NO20024246D0 (no) | Endret stamme av det modifiserte vacciniaviruset (Ankara MVA) | |
| ATE320493T1 (de) | Modifizierung des hepatitis b kernantigens | |
| DK1255826T3 (da) | Automatisering af proteindesign for proteinbiblioteker | |
| ATE227134T1 (de) | Chitosan-impfstoff-zusammensetzungen zur intranasalen verabreichung und anwendungen | |
| MY125202A (en) | Vaccine | |
| WO2006042027A8 (en) | Immunogenic and therapeutic compositions for streptococcus pyogenes | |
| DE60138014D1 (de) | Chimäre arterivirus-ähnliche partikel | |
| AP2002002685A0 (en) | Use of flavivirus for the expression of protein epitpoes and development of new live attenuated vaccine virus to immune against flavivirus and other infectious agents | |
| AP2003002734A0 (en) | Purification of HBV antigens for use in vaccines. | |
| DE60226175D1 (de) | Mycobakterieller impfstoff | |
| ATE335739T1 (de) | Cak inhibitoren und deren verwendungen | |
| IL156799A0 (en) | Peptides having affinity for the gp120 viral protein and use thereof | |
| DE60235223D1 (de) | Streptococcus pyogenes polypeptide und entsprechende dna fragmente | |
| EP1543838A4 (en) | Vaccine against infectious CAT PERITONITIS | |
| SG147465A1 (en) | Vaccine | |
| DK0792347T3 (da) | Fremgangsmåder til fremstilling af forbedrede antigene Heliobacter sp. og vacciner omfattende samme | |
| DE60234772D1 (de) | Gruppe-b streptococcus antigene und entsprechende dna-fragmente | |
| WO2003059252A3 (en) | Use of a novel cell surface protease from group b streptococcus | |
| DK1275638T3 (da) | Kombinationspræparat til behandling af immunologiske sygdomme |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |